Authors:
Hanamura, I
Iida, S
Akano, Y
Hayami, Y
Kato, M
Miura, K
Harada, S
Banno, S
Wakita, A
Kiyoi, H
Naoe, T
Shimizu, S
Sonta, S
Nitta, M
Taniwaki, M
Ueda, R
Citation: I. Hanamura et al., Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations, JPN J CANC, 92(6), 2001, pp. 638-644
Authors:
Kosugi, H
Ito, M
Yamamoto, Y
Towatari, M
Ito, M
Ueda, R
Saito, H
Naoe, T
Citation: H. Kosugi et al., In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice, JPN J CANC, 92(5), 2001, pp. 529-536
Citation: S. Kunishima et al., Novel heterozygous missense mutation in the platelet glycoprotein Ib beta gene associated with isolated giant platelet disorder, AM J HEMAT, 68(4), 2001, pp. 249-255
Authors:
Hirose, Y
Kiyoi, H
Itoh, K
Kato, K
Saito, H
Naoe, T
Citation: Y. Hirose et al., B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells, IMMUNOLOGY, 104(4), 2001, pp. 410-417
Authors:
Yamamoto, Y
Kiyoi, H
Nakano, Y
Suzuki, R
Kodera, Y
Miyawaki, S
Asou, N
Kuriyama, K
Yagasaki, F
Shimazaki, C
Akiyama, H
Saito, K
Nishimura, M
Motoji, T
Shinagawa, K
Takeshita, A
Saito, H
Ueda, R
Ohno, R
Naoe, T
Citation: Y. Yamamoto et al., Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies, BLOOD, 97(8), 2001, pp. 2434-2439
Authors:
Naoe, T
Takeyama, K
Yokozawa, T
Kiyoi, H
Seto, M
Uike, N
Ino, T
Utsunomiya, A
Maruta, A
Jin-Nai, I
Kamada, N
Kubota, Y
Nakamura, H
Shimazaki, C
Horiike, S
Kodera, Y
Saito, H
Ueda, R
Wiemels, J
Ohno, R
Citation: T. Naoe et al., Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia, CLIN CANC R, 6(10), 2000, pp. 4091-4095
Authors:
Hayakawa, F
Towatari, M
Kiyoi, H
Tanimoto, M
Kitamura, T
Saito, H
Naoe, T
Citation: F. Hayakawa et al., Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines, ONCOGENE, 19(5), 2000, pp. 624-631
Authors:
Murata, M
Towatari, M
Kosugi, H
Tanimoto, M
Ueda, R
Saito, H
Naoe, T
Citation: M. Murata et al., Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells, JPN J CANC, 91(11), 2000, pp. 1154-1160
Authors:
Nakano, Y
Naoe, T
Kiyoi, H
Kitamura, K
Minami, S
Miyawaki, S
Asou, N
Kuriyama, K
Kusumoto, S
Shimazaki, C
Akiyama, H
Saito, K
Nishimura, M
Motoji, T
Shinagawa, K
Saito, H
Ohno, R
Citation: Y. Nakano et al., Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia, EUR J HAEMA, 65(1), 2000, pp. 23-31
Authors:
Zhao, M
Kiyoi, H
Yamamoto, Y
Ito, M
Towatari, M
Omura, S
Kitamura, T
Ueda, R
Saito, H
Naoe, T
Citation: M. Zhao et al., In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor, LEUKEMIA, 14(3), 2000, pp. 374-378
Authors:
Kitamura, K
Minami, Y
Yamamoto, K
Akao, Y
Kiyoi, H
Saito, H
Naoe, T
Citation: K. Kitamura et al., Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis, LEUKEMIA, 14(10), 2000, pp. 1743-1750
Authors:
Yokozawa, T
Towatari, M
Iida, H
Takeyama, K
Tanimoto, M
Kiyoi, H
Motoji, T
Asou, N
Saito, K
Takeuchi, M
Kobayashi, Y
Miyawaki, S
Kodera, Y
Ohno, R
Saito, H
Naoe, T
Citation: T. Yokozawa et al., Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia, LEUKEMIA, 14(1), 2000, pp. 28-33
Authors:
Kitamura, K
Hoshi, S
Koike, M
Kiyoi, H
Saito, H
Naoe, T
Citation: K. Kitamura et al., Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid, BR J HAEM, 108(4), 2000, pp. 696-702
Authors:
Takeshita, A
Shinjo, K
Naito, K
Ohnishi, K
Sugimoto, Y
Yamakawa, Y
Tanimoto, M
Kitamura, K
Naoe, T
Ouno, R
Citation: A. Takeshita et al., Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA, BR J HAEM, 108(1), 2000, pp. 90-92
Authors:
Yoshida, M
Tsubaki, K
Kobayashi, T
Tanimoto, M
Kuriyama, K
Murakami, H
Minami, S
Hiraoka, A
Takahashi, I
Naoe, T
Asou, N
Kageyama, S
Tomonaga, M
Saito, H
Ohno, R
Citation: M. Yoshida et al., Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991, INT J HEMAT, 70(4), 1999, pp. 261-267
Authors:
Miyawaki, S
Kobayashi, T
Tanimoto, M
Kuriyama, K
Murakami, H
Yoshida, M
Minami, S
Minato, K
Tsubaki, K
Omoto, E
Oh, H
Jinnai, I
Sakamaki, H
Hiraoka, A
Kanamura, A
Takahashi, I
Saito, K
Naoe, T
Yamada, O
Asou, N
Kageyama, S
Emi, N
Ueda, T
Tomonaga, M
Saito, H
Ueda, R
Ohno, R
Citation: S. Miyawaki et al., Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy, INT J HEMAT, 70(1), 1999, pp. 56-57
Authors:
Kosugi, H
Towatari, M
Hatano, S
Kitamura, K
Kiyoi, H
Kinoshita, T
Tanimoto, M
Murate, T
Kawashima, K
Saito, H
Naoe, T
Citation: H. Kosugi et al., Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy, LEUKEMIA, 13(9), 1999, pp. 1316-1324
Citation: H. Kiyoi et T. Naoe, Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells, LEUKEMIA, 13(5), 1999, pp. 829-830
Authors:
Yanagi, M
Shinjo, K
Takeshita, A
Tobita, T
Yano, K
Kobayashi, M
Terasaki, H
Naoe, T
Ohnishi, K
Ohno, R
Citation: M. Yanagi et al., Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells, LEUKEMIA, 13(4), 1999, pp. 542-552